ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

USFDA pulls up Natco Pharma for several violations at Telangana plant
Natco Pharma failed to maintain cleanliness, sterilise equipment and utensils at appropriate intervals at its Telangana-based plant, as per the US health regulator. In the warning letter to the company, US Food and Drug Administration said its investigator
Announcement as on 21 April 2024

Complaint filed against Natco Pharma in US by Fresenius Kabi
Natco Pharma faces a legal complaint from Fresenius Kabi in the US District Court regarding the marketing of Diazepam injection prefilled syringe. Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH filed the complaint against Natco Pharma USA LLC
Announcement as on 18 April 2024

Natco Pharma receives warning letter from USFDA for Telangana plant
Natco Pharma on Tuesday said it has received a warning letter from the US health regulator for its Telangana-based manufacturing plant. The US Food and Drug Administration (USFDA) had issued eight observations under Form 483 after inspecting the company's
Announcement as on 09 April 2024

Natco Pharma gets warning letter from USFDA for Telangana plant
Natco Pharma, a pharmaceutical company, received a warning letter from the USFDA regarding its manufacturing plant in Telangana. This came after the FDA conducted an inspection of the company's facility in Kothur last October, issuing eight observations un
Announcement as on 09 April 2024

Accumulate NATCO Pharma; target of Rs 1116: Geojit Financial Services
Geojit Financial Services recommended accumulate rating on NATCO Pharma with a target price of Rs 1116 in its research report dated March 27, 2024.
Announcement as on 27 March 2024

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 788.68
  • 12Day Average: 810.28
  • 20Day Average: 814.97
  • 50Day Average: 851.34
  • 100Day Average: 901.44
  • 150Day Average: 955.28
  • 200Day Average: 936.22

524816 Indicators & signals

Indicator MACD (12,26,9)

804.54, 820.91, -15.23
Indicator MACD is in negative zone

Indicator ADX (14)

16.52, 15.97, 22.3
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 44
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Mon Oct 2026 800.75 778.75 to 809.75 1.97% 2.13 times
16 Fri Oct 2026 785.25 781.00 to 788.50 0.06% 0.3 times
15 Thu Oct 2026 784.80 780.00 to 787.75 0.23% 0.72 times
14 Wed Oct 2026 783.00 781.00 to 794.85 -0.84% 1.06 times
13 Tue Oct 2026 789.60 787.50 to 803.55 -1.32% 0.41 times
12 Mon Oct 2026 800.20 789.10 to 804.15 -2.85% 1.31 times
06 Tue Oct 2026 823.70 815.55 to 826.00 0.19% 0.89 times
05 Mon Oct 2026 822.15 801.35 to 827.65 0.05% 1.25 times
01 Thu Oct 2026 821.75 803.30 to 826.75 -2.63% 0.91 times
29 Tue Sep 2026 843.95 827.90 to 851.65 1.91% 0.98 times
28 Mon Sep 2026 828.10 824.00 to 856.30 -1.42% 2.18 times
25 Fri Sep 2026 840.05 835.00 to 850.20 -0.21% 0.63 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top